Newman Dignan & Sheerar »

Adaptimmune Therapeutics shares owned by Newman Dignan & Sheerar

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Newman Dignan & Sheerar from 13F filings

Historical chart of Newman Dignan & Sheerar investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Newman Dignan & Sheerar consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Newman Dignan & Sheerar

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 23k 0.79
2023-06-30 $18k 19k 0.93

More positions owned by Newman Dignan & Sheerar

Schwab Dow Jones US Large Cap ETF Etf (SCHX)
Schwab Dow Jones US Div Eq ETF Etf (SCHD)
Applied Finance Valuation Lg Cap ETF Etf (VSLU)
Microsoft Corporation (MSFT)
Apple (AAPL)
ETFS Phys. Swiss Gold Shares Etf (SGOL)
Alphabet Inc Class A cs (GOOGL)
Proshares S&P 500 Div Aristocrats Etf (NOBL)
Dimensional Emerg Core Equity Mkt ETF Etf (DFAE)
Merck & Co (MRK)
Schwab Dow Jones US Mid-Cap ETF Etf (SCHM)
NVIDIA Corporation (NVDA)
First Trust TCWOpportunistic Fxd Inc ETF Etf (FIXD)
Schwab Dow Jones US Large Growth ETF Etf (SCHG)
Vanguard S&P 500 ETF Etf (VOO)

View all positions for Newman Dignan & Sheerar

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
GSA Capital Partners
Acuitas Investments
Millennium Management
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics